Share
     
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

Although PrEP has been recommended by WHO since 2015, implementation in Latin America has been limited. This symposium will take stock of current advances and lessons learned in the implementation of PrEP in Latin America, highlighting successful approaches, enabling factors and challenges to scale-up and why PrEP could be an important addition to efforts to reach epidemic control in the region. The session will present experiences from the ImPrEP project in Brazil, Mexico and Peru and discuss challenges in reaching vulnerable MSM and TGW, particularly the younger and lower incomes populations; debate strategies for improving PrEP continuation; present data on the need for STI screening and treatment; analyze successful strategies and innovations for reaching, enrolling and retaining TGW, highlight community perspectives on engagement and demand creation for PrEP services; and examine the specific socio-economic regional landscape on PrEP-drugs, such as regulatory issues, patents and costing. This symposium

18:30
Welcome from UNITAID
Jose Mauricio Cysne, UNITAID, Switzerland
18:33
Objectives of the symposium and overview of ImPrEP
Valdiléa G. Veloso, Fundação Oswaldo Cruz, Rio de Janeiro (FIOCRUZ), Brazil
18:38
Challenges for reaching younger and more vulnerable MSM and TGW
Carlos Fernando Cáceres, Universidad Peruana Cayetano Heredia, Peru
Slides
18:53
Challenges for PrEP continuation
Hamid Vega-Ramírez, Ramon de la Fuente Muñoz National Institute of Psychiatry, Mexico
Slides
19:08
STIs in the context of PrEP programs
Valdiléa G. Veloso, Fundação Oswaldo Cruz, Rio de Janeiro (FIOCRUZ), Brazil
Slides
19:23
Community engagement: perspectives on reaching and enrolling MSM and TGW in PrEP
Alessandra Ramos, Instituto Transformar, Brazil
PDF
19:38
Regional landscape on PrEP drug patents, licensing and costs
Felipe de Carvalho Borges da Fonseca, ABIA - Brazilian Interdisciplinary AIDS Association, Brazil
Slides